DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
All outstanding objections and rejections, except for those maintained below, are withdrawn in light of applicant's amendment filed on 8/24/2026.
The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior office action.
The new grounds of rejection set forth below are necessitated by applicant's amendment filed on 8/24/2026. In particular, the scope of original Claim 42 has been narrowed from that previously recited, i.e. Compound H-6 has been deleted from the claim. Thus, the following action is properly made final.
Claim Rejections - 35 USC § 102
The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action.
Claims 42-45 are rejected under 35 U.S.C. 102(a1) as being anticipated by Pflumm et al (US 2012/0326141).
Regarding claim 42, Pflumm et al discloses the following compound (Page 11):
PNG
media_image1.png
206
438
media_image1.png
Greyscale
,
identical to H-5 recited in the present claims.
Regarding claim 43, Pflumm et al teaches all the claim limitations as set forth above. Additionally, the reference discloses an organic light emitting device comprising the disclosed compound (Abstract, [0008], and [0071]).
Regarding claim 44, Pflumm et al teaches all the claim limitations as set forth above. Additionally, the reference discloses that the compound (disclosed as HTM-1 – [0071]) is present in the hole transport layer of the device ([0008]).
Regarding claim 45, Pflumm et al teaches all the claim limitations as set forth above. Additionally, the reference discloses that the compound (disclosed as HTM-1 – [0071]) is present in the hole transport layer of the device ([0008]).
In light of the above, it is clear that Pflumm et al anticipates the presently recited claims.
Allowable Subject Matter
Claims 23-28, 30, 32, and 34-41 are allowable over the “closest” prior art for the reasons set forth below.
Pflumm et al discloses an organic light emitting device, i.e. an electronic device, where the hole transport layer comprises a mixture of two (2) hole transporting materials (HTM), i.e. HTM-1 and HTM-2. HTM-1 is a triarylamine compound ([0041]-[0042]) with the formula ([0042] – Formula 1):
PNG
media_image2.png
118
133
media_image2.png
Greyscale
,
where Ar1, on each occurrence is a monovalent aromatic ring system having 5 to 60 aromatic ring atoms ([0043]). Such ring systems are exemplified as 9,9’-spirobifluorene ([0063]), i.e.
PNG
media_image3.png
174
195
media_image3.png
Greyscale
and benzene ([0064]). Compound HTM-2 corresponds to formulas such as.
PNG
media_image4.png
120
190
media_image4.png
Greyscale
,
PNG
media_image5.png
108
224
media_image5.png
Greyscale
.
However, claim 23 has been amended deleting the groups N(R3)2 and NR3. Thus, the compounds encompassed by the present claims can only have a single amine group, while the HMT-2 compounds disclosed by the reference possess two (2) amine groups. Accordingly, the reference discloses compounds outside the scope of the present claims, and the reference does not disclose or suggest the combination of compounds in the hole transport layer as required by claims 23.
Response to Arguments
Applicants’ arguments filed 8/24/2026 have been fully considered but they are not persuasive.
In light of the amendments to the claims, the 35 U.S.C. 112 (b) rejections set forth in the previous Office Action are withdrawn.
Applicants argue that Pflumm et al does not disclose the compounds as recited in claim 42 as amended. However, as discussed in the rejections set forth above, the reference discloses the following compound:
PNG
media_image1.png
206
438
media_image1.png
Greyscale
,
identical to H-5 recited in the present claims.
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEXANDER C. KOLLIAS whose telephone number is (571)-270-3869. The examiner can normally be reached on Monday-Friday, 8:00AM – 5:00 PM EST.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd can be reached on (571)-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ALEXANDER C KOLLIAS/Primary Examiner, Art Unit 1786
Prosecution Insights